{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:44:41Z","timestamp":1791492281374,"version":"4.3.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.dld.2020.10.039","type":"journal-article","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T09:51:59Z","timestamp":1606125119000},"page":"94-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":155,"title":["Safety and efficacy of remimazolam in high risk colonoscopy: A randomized trial"],"prefix":"10.1016","volume":"53","author":[{"given":"Douglas K.","family":"Rex","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Bhandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.","family":"Lorch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Meyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Schippers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2020.10.039_bib0001","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/j.1572-0241.2006.00500.x","article-title":"Endoscopic Sedation in the United States: results from a nationwide survey","volume":"101","author":"Cohen","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2020.10.039_bib0002","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.annemergmed.2006.09.020","article-title":"Research advances in procedural sedation and analgesia","volume":"49","author":"Green","year":"2007","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.dld.2020.10.039_bib0003","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000076543","article-title":"The dawning of a new sedative: propofol in gastrointestinal endoscopy","volume":"69","author":"Heuss","year":"2004","journal-title":"Digestion"},{"key":"10.1016\/j.dld.2020.10.039_bib0004","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.annemergmed.2006.06.042","article-title":"Randomized clinical trial of etomidate versus propofol for procedural sedation in the emergency department","volume":"49","author":"Miner","year":"2007","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.dld.2020.10.039_bib0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1197\/j.aem.2006.05.023","article-title":"Procedural sedation in the community emergency department: initial results of the prosced registry","volume":"14","author":"Sacchetti","year":"2007","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.dld.2020.10.039_bib0006","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/emj.2007.046714","article-title":"Propofol for procedural sedation in the emergency department","volume":"24","author":"Dunn","year":"2007","journal-title":"Emerg Med J"},{"key":"10.1016\/j.dld.2020.10.039_bib0007","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ajem.2006.02.008","article-title":"Propofol by infusion protocol for Ed procedural sedation","volume":"24","author":"Frank","year":"2006","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.dld.2020.10.039_bib0008","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2165\/11204450-000000000-00000","article-title":"Fospropofol","volume":"70","author":"Garnock-Jones","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.dld.2020.10.039_bib0009","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.emc.2004.12.016","article-title":"Procedural sedation and analgesia in the emergency department: what are the risks?","volume":"23","author":"Miller","year":"2005","journal-title":"Emerg Med Clin North Am"},{"key":"10.1016\/j.dld.2020.10.039_bib0010","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.emc.2004.12.013","article-title":"Procedural sedation and analgesia: a review and new concepts","volume":"23","author":"Bahn","year":"2005","journal-title":"Emerg Med Clin North Am"},{"key":"10.1016\/j.dld.2020.10.039_bib0011","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/01.anes.0000267503.85085.c0","article-title":"Cns 7056: a novel ultra-short-acting benzodiazepine","volume":"107","author":"Kilpatrick","year":"2007","journal-title":"Anesthesiology"},{"key":"10.1016\/j.dld.2020.10.039_bib0012","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/ACO.0000000000000877","article-title":"Remimazolam for anaesthesia or sedation","volume":"33","author":"Sneyd","year":"2020","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.dld.2020.10.039_bib0013","first-page":"929","article-title":"Remimazolam, a short-acting Gaba(a) receptor agonist for intravenous sedation and\/or anesthesia in day-case surgical and non-surgical procedures","volume":"13","author":"Rogers","year":"2010","journal-title":"IDrugs"},{"key":"10.1016\/j.dld.2020.10.039_bib0014","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1213\/ANE.0b013e31823f0c28","article-title":"A placebo- and midazolam-controlled phase i single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (Cns 7056): part I. Safety, efficacy, and basic pharmacokinetics","volume":"115","author":"Antonik","year":"2012","journal-title":"Anesth Analg"},{"key":"10.1016\/j.dld.2020.10.039_bib0015","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.gie.2018.04.2351","article-title":"A phase III Study evaluating the efficacy and safety of remimazolam (Cns 7056) compared with placebo and midazolam in patients undergoing colonoscopy","volume":"88","author":"Rex","year":"2018","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.dld.2020.10.039_bib0016","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1213\/ANE.0b013e318241f68a","article-title":"A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (Cns 7056): part II. Population pharmacokinetic and pharmacodynamic modeling and simulation","volume":"115","author":"Wiltshire","year":"2012","journal-title":"Anesth Analg"},{"key":"10.1016\/j.dld.2020.10.039_bib0017","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1213\/ANE.0b013e3182a705ae","article-title":"A Phase Ib, dose-finding study of multiple doses of remimazolam (Cns 7056) in volunteers undergoing colonoscopy","volume":"117","author":"Worthington","year":"2013","journal-title":"Anesth Analg"},{"key":"10.1016\/j.dld.2020.10.039_bib0018","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.gie.2012.11.039","article-title":"Is the American society of anesthesiologists classification useful in risk stratification for endoscopic procedures?","volume":"77","author":"Enestvedt","year":"2013","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.dld.2020.10.039_bib0019","unstructured":"NIDDK: Clinical Outcomes Research Initiative (CORI). (Accessed 22 Sep, 2020, at https:\/\/repository.niddk.nih.gov\/studies\/cori\/)."},{"key":"10.1016\/j.dld.2020.10.039_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.gie.2018.04.2351","article-title":"A phase III study evaluating the efficacy and safety of remimazolam (Cns 7056) compared with placebo and midazolam in patients undergoing colonoscopy","author":"Rex","year":"2018","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.dld.2020.10.039_bib0021","unstructured":"Drug Trials Snapshots: Byfavo. FDA, 2020. (Accessed 22 Sep, 2020, at https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/drug-trials-snapshots-byfavo)."},{"key":"10.1016\/j.dld.2020.10.039_bib0022","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.gie.2017.07.018","article-title":"Guidelines for sedation and anesthesia in GI endoscopy","volume":"87","author":"Committee ASoP","year":"2018","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.dld.2020.10.039_bib0023","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1055\/s-0034-1393414","article-title":"Non-anesthesiologist administration of propofol for gastrointestinal endoscopy: european society of gastrointestinal endoscopy, European society of gastroenterology and endoscopy nurses and associates guideline-updated june 2015","volume":"47","author":"Dumonceau","year":"2015","journal-title":"Endoscopy"},{"key":"10.1016\/j.dld.2020.10.039_bib0024","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/EJA.0000000000000683","article-title":"European society of anaesthesiology and European board of anaesthesiology guidelines for procedural sedation and analgesia in adults","volume":"35","author":"Hinkelbein","year":"2018","journal-title":"Eur J Anaesthesiol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865820309944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865820309944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:15:07Z","timestamp":1761624907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865820309944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1590865820309944"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2020.10.039","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of remimazolam in high risk colonoscopy: A randomized trial","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2020.10.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}